Cycad Group
VC
INVESTOR TYPE
Active
STATUS
4
PROFESSIONALS
41
INVESTMENTS
10
PORTFOLIO
21
EXITS
Description
Cycad Group is a venture capital firm based in Santa Barbara, California. The firm seeks to invest in companies operating in the energy technologies, advanced materials, chemical processes, life sciences, biotechnology, pharmaceuticals, medical devices and analytical tools sectors.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2000
Primary Investor Type
Venture Capital
Primary Office
- 1270 Coast Village Circle
- Suite 100
- Santa Barbara, CA 93108
- United States
+1 (805) 000-0000
Cycad Group Investments (41)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Visterra | 05-Oct-2017 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | |
| 00000000 | 14-Sep-2017 | 00000 00000 | 00.000 | Biotechnology | Clinical Trials - General | 0. 0000000 000000 00 |
| 00000 000000000000 | 21-Aug-2017 | 00000 00000 | 00000 | Biotechnology | Pre-Clinical Trials | |
| 00000000 000000000 | 03-Aug-2017 | 00000 00000 | 00000 | Drug Discovery | Profitable | |
| 000000000 0000000 | 13-May-2015 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 000000 00000 |
| 00000000 | 15-May-2014 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | |
| 00000000 | 08-May-2014 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - General | 0. 0000000 000000 00 |
| 00000 | 15-Oct-2013 | 00000 00000 | 000 | Diagnostic Equipment | Profitable | 0. 0000000 000000 00 |
| Genocea Biosciences | 02-Jul-2013 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - General | |
| Lixivia (Rare Earth Elements) | 28-Feb-2013 | Early Stage VC | 00000 | Industrial Chemicals | Generating Revenue | 0. 0000000 000000 00 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cycad Group’s full profile, request a free trial.
Cycad Group Exits (21)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Visterra | 31-Aug-2018 | Merger/Acquisition | 00000 | Completed |
|
| 00000 000000000000 | 03-May-2018 | 000 | 0000 | Completed |
|
| 000000000 0000000 | 15-Dec-2017 | 000000000000000000 | Completed |
|
|
| 0000000 0000000000 | 05-Feb-2014 | 000 | 0000 | Completed |
|
| 00000 000000 | 01-Feb-2014 | 000 00 00000000 | Completed |
|
|
| 000000 00000 | 01-Jan-2014 | 0000000000: 000000 | Completed |
|
|
| 000000000000000 | 01-Jan-2014 | 0000000000: 000000 | Completed |
|
|
| 00000 00 | 01-Aug-2013 | 000 00 00000000 | Completed |
|
|
| Tioga Energy | 08-Jul-2013 | Merger/Acquisition | Completed | ||
| OvaScience | 13-Nov-2012 | IPO | 000.00 | Completed |
|
Cycad Group Team (4)
Cycad Group Co-Investors (48)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Baillie Gifford | 2 | 0 | |
| Bill & Melinda Gates Foundation | 0 | 0 | 0 |
| Bezos Expeditions | 0 | 0 | 0 |
| Founders Fund | 0 | 0 | |
| Luxin Venture Capital Group Company | 0 |